UK Biobank analysis shows that people with type 2 diabetes have higher liver fat (PDFF) and fibro-inflammation (cT1) and lower skeletal muscle index than non-diabetic controls. In addition, LiverMultiScan detected greater liver damage in participants with T2D despite normal liver biochemistry (AST/ALT).